BEYONTTRA 356 mg film-coated tablets
23026
Approved small_molecule active
Quick answer
BEYONTTRA 356 mg film-coated tablets for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a Approved program (small_molecule) at Bayer Schering Pharma AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer Schering Pharma AG
- Indication
- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active